Christine Ring
Vermögen: 241 163 $ am 31.05.2026
Vermögen: 241 163 $ am 31.05.2026
Christine Ring is currently Chairman at BIOMILQ, Inc. since 2023 and Secretary, Chief Legal & Compliance Officer at Nurix Therapeutics, Inc. since 2023.
Former positions include Principal at Kosan Biosciences, Inc., Principal at Sunesis Pharmaceuticals, Inc., Senior VP & Chief Intellectual Property Counsel at Amyris, Inc. in 2014, Principal at Pillsbury Madison & Sutro LLP, and Senior Vice President-Legal at Dermira, Inc. from 2018 to 2019.
Education includes graduate studies at Hastings College, undergraduate studies at the University of California, Berkeley, and a doctorate from the University of California, San Francisco.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NURIX THERAPEUTICS, INC. 0,01 % | 02.06.2026 | 13 579 ( 0,01 % ) | 241 163 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Compliance Officer | 01.10.2023 |
BIOMILQ, Inc.
BIOMILQ, Inc. Miscellaneous Commercial ServicesCommercial Services Provides mammary biotechnology services | Vorsitzender | 01.03.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
| DERMIRA, INC. | General Counsel | 01.04.2019 |
Pillsbury Madison & Sutro LLP
Pillsbury Madison & Sutro LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
| VIRACTA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer therapeutics | Corporate Officer/Principal | - |
| AMYRIS, INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer therapeutics | Health Technology |
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Amyris, Inc.
Amyris, Inc. Chemicals: SpecialtyProcess Industries Operates as a biomanufacturing company that uses renewable biological chemistry | Process Industries |
Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Pillsbury Madison & Sutro LLP
Pillsbury Madison & Sutro LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Hastings College
Hastings College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dermira, Inc.
Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
BIOMILQ, Inc.
BIOMILQ, Inc. Miscellaneous Commercial ServicesCommercial Services Provides mammary biotechnology services | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen